| Primary |
| Prophylaxis Of Nausea And Vomiting |
32.6% |
| Chemotherapy |
16.3% |
| Breast Cancer |
7.7% |
| Prophylaxis |
6.3% |
| Pain |
5.0% |
| Bone Sarcoma |
4.1% |
| Nausea |
3.6% |
| Analgesic Therapy |
3.2% |
| Infection Prophylaxis |
3.2% |
| Vomiting |
3.2% |
| Antifungal Prophylaxis |
2.3% |
| Lung Neoplasm Malignant |
2.3% |
| Infection |
1.8% |
| Breast Neoplasm |
1.4% |
| Fluid Replacement |
1.4% |
| Premedication |
1.4% |
| Synovial Sarcoma |
1.4% |
| Yolk Sac Tumour Site Unspecified |
1.4% |
| Bladder Cancer |
0.9% |
| Constipation Prophylaxis |
0.9% |
|
| Electrocardiogram T Wave Inversion |
14.7% |
| Febrile Neutropenia |
8.8% |
| Hiccups |
8.8% |
| Swollen Tongue |
8.8% |
| Non-cardiac Chest Pain |
5.9% |
| Pancreatitis |
5.9% |
| Pyrexia |
5.9% |
| Sepsis |
5.9% |
| Anaphylactic Shock |
2.9% |
| Atrial Fibrillation |
2.9% |
| Cellulitis |
2.9% |
| Clostridium Difficile Infection |
2.9% |
| Drug Interaction |
2.9% |
| Dyspnoea |
2.9% |
| Flank Pain |
2.9% |
| Haematuria |
2.9% |
| Hyponatraemia |
2.9% |
| Hypophagia |
2.9% |
| Logorrhoea |
2.9% |
| Nausea |
2.9% |
|
| Secondary |
| Prophylaxis Of Nausea And Vomiting |
36.7% |
| Chemotherapy |
7.7% |
| Pain |
6.0% |
| Analgesic Therapy |
6.0% |
| Product Used For Unknown Indication |
5.5% |
| Mucosal Inflammation |
5.1% |
| Prophylaxis |
5.0% |
| Infection |
3.6% |
| Constipation |
3.0% |
| Neoplasm Malignant |
3.0% |
| Bone Sarcoma |
2.5% |
| Antiemetic Supportive Care |
2.5% |
| Nausea |
2.3% |
| Anticoagulant Therapy |
2.0% |
| Anaesthesia |
1.9% |
| Device Related Infection |
1.7% |
| Menstrual Disorder |
1.7% |
| Haemoglobin Decreased |
1.5% |
| Vomiting |
1.2% |
| Fluid Replacement |
1.1% |
|
| Vena Cava Thrombosis |
38.2% |
| Off Label Use |
6.9% |
| Febrile Neutropenia |
6.0% |
| Sinus Arrhythmia |
5.2% |
| Lung Cancer Metastatic |
4.3% |
| Vomiting |
4.3% |
| Electrocardiogram T Wave Inversion |
3.9% |
| Rhinorrhoea |
3.9% |
| Swollen Tongue |
3.9% |
| Peritonitis |
3.0% |
| Large Intestine Perforation |
2.6% |
| Small Intestinal Haemorrhage |
2.6% |
| Thrombocytopenia |
2.6% |
| Haematuria |
2.1% |
| Pain In Extremity |
2.1% |
| Pyrexia |
2.1% |
| Constipation |
1.7% |
| Malaise |
1.7% |
| Somnolence |
1.7% |
| Abdominal Pain |
1.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
20.5% |
| Product Used For Unknown Indication |
16.3% |
| Prophylaxis |
10.8% |
| Breast Cancer |
9.7% |
| Nausea |
8.4% |
| Non-small Cell Lung Cancer |
5.1% |
| Vomiting |
3.6% |
| Pain |
2.9% |
| Prophylaxis Of Nausea And Vomiting |
2.8% |
| Premedication |
2.6% |
| Sarcoma Metastatic |
2.4% |
| Gastric Cancer |
2.4% |
| Chemotherapy |
2.1% |
| Hypertension |
2.0% |
| Head And Neck Cancer |
1.9% |
| Ovarian Cancer |
1.5% |
| Constipation |
1.4% |
| Diarrhoea |
1.3% |
| Stomatitis |
1.1% |
| B-cell Lymphoma |
1.1% |
|
| Vomiting |
17.2% |
| Febrile Neutropenia |
8.1% |
| Thrombocytopenia |
8.1% |
| Pyrexia |
6.5% |
| Pulmonary Embolism |
5.5% |
| Small Intestinal Obstruction |
5.2% |
| Diarrhoea |
4.9% |
| White Blood Cell Count Decreased |
4.9% |
| Death |
4.5% |
| Septic Shock |
4.5% |
| Pleural Effusion |
3.9% |
| Renal Failure |
3.6% |
| Renal Failure Acute |
3.6% |
| Hypomagnesaemia |
3.2% |
| Oral Candidiasis |
3.2% |
| Pneumonia |
2.9% |
| Abdominal Pain |
2.6% |
| Deafness Neurosensory |
2.6% |
| Left Ventricular Dysfunction |
2.6% |
| Mucosal Inflammation |
2.6% |
|
| Interacting |
| Premedication |
24.1% |
| Ovarian Cancer Stage Iii |
16.9% |
| Prophylaxis Of Nausea And Vomiting |
16.9% |
| Sarcoma Uterus |
14.5% |
| Ovarian Neoplasm |
7.2% |
| Anxiety |
4.8% |
| Depression |
4.8% |
| Ovarian Cancer Metastatic |
4.8% |
| Bone Sarcoma |
3.6% |
| Laryngeal Cancer Stage 0 |
2.4% |
|
| Mental Status Changes |
31.3% |
| Vomiting |
31.3% |
| Renal Impairment |
25.0% |
| Encephalopathy |
6.3% |
| Transaminases Increased |
6.3% |
|
